Quarterly Results:

Both core segments posted gains. Ambulatory care adjusted EBITDA grew about 9.4%, while hospital business adjusted EBITDA also expanded, supported by higher acuity and revenue mix improvements.

Full-Year Context:

For the full year 2025, net operating revenues reached $21.31 billion, up from $20.68 billion in 2024. Adjusted EBITDA grew to $4.566 billion from $3.995 billion, and full-year adjusted diluted EPS increased to $16.78 from $11.88. Free cash flow more than doubled year-over-year to $2.53 billion, driven by higher operating cash flows.

Net income for 2025 was lower compared with 2024 owing to a large one-time gain in the prior year linked to hospital divestitures, which boosted 2024 reported earnings.

2026 Outlook:

Tenet provided FY 2026 guidance for net operating revenues between $21.5 billion and $22.3 billion and adjusted EBITDA of $4.485 billion to $4.785 billion. The company expects adjusted diluted EPS in a range that analysts project to be roughly in line with current consensus estimates.

Management noted continued demand for acute care and ambulatory surgical services. Cash flow and balance sheet metrics are expected to remain robust, with modest leverage improvements year-over-year.

Sector/Macro Pressure:

Healthcare services stocks, including hospital operators like Tenet, are trading in a broader market context of mixed macro signals. Interest rates and cost pressures in the wider economy have weighed on valuation multiples for some healthcare and software/SaaS names alike, though hospital services often show defensive characteristics. However, caution among investors on growth stocks persists amid macro uncertainty.

52-Week and Trend:

Tenet’s share price has climbed significantly from lows near the $110 area over the past year and has shown relative resilience in recent months, though shares remain below the 52-week high. Trading patterns suggest a positive longer-term trend with periodic volatility around earnings and macroeconomic news.